Author

Qiang Dong

Institutions: Sichuan University, West China Hospital of Sichuan University

Observed institutions: Guiyang Medical University, Sichuan University, West China Hospital of Sichuan University, Affiliated Hospital of Guizhou Medical University

ORCID: 0009-0001-1837-2561

Observed ORCID: 0009-0001-1837-2561

OpenAlex ID: A5111242305

Di-(2-ethylhexyl) phthalate promotes benign prostatic hyperplasia through KIF11-Wnt/β-catenin signaling pathway

2024 · Pan Song, Dong Lv, et al. · Ecotoxicology and Environmental Safety · 18

Elucidating the therapeutic mechanisms of resveratrol in benign prostatic hyperplasia via an integrated strategy of network pharmacology, multi-omics and molecular biology

2025 · Jinze Li, Yin Huang, et al. · Phytomedicine · 5

SIRT7 inhibits the aging and inflammatory damage of hPDLFs by suppressing the AKT/mTOR

2024 · Jinyi Sun, Ying Li, et al. · International Immunopharmacology · 5

Myeloid-derived suppressor cells promote therapy-induced resistance in prostate cancer

2026 · Anlin Liu, Pan Song, et al. · International Journal of Surgery · 1

Cepharanthine may inhibit the proliferation of prostate cells by blocking the EGFR/PI3K/AKT signaling pathway: comprehensive network analysis, molecular docking, and experimental evaluation

2025 · Yin Huang, Jingxing Bai, et al. · Frontiers in Pharmacology · 1

Works count: 5

Citation count: 30

H-index: 3

I10-index: 1